Format

Send to

Choose Destination
Anatol J Cardiol. 2020 Feb;23(3):160-168. doi: 10.14744/AnatolJCardiol.2019.87894.

Snapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality.

Author information

1
Department of Cardiology, Faculty of Medicine, Dokuz Eylül University; İzmir-Turkey.
2
Department of Cardiology, Erzurum Regional Training and Research Hospital; Erzurum-Turkey.
3
Department of Cardiology, Faculty of Medicine, Başkent University; İstanbul-Turkey.
4
Department of Cardiology, Faculty of Medicine, Kırıkkale University; Kırıkkale-Turkey.
5
Department of Cardiology, Faculty of Medicine, Mersin University; Mersin-Turkey.
6
Department of Cardiology, Faculty of Medicine, Dicle University; Diyarbakır-Turkey.
7
Department of Cardiology, Faculty of Medicine, Hitit University; Çorum-Turkey.
8
Department of Cardiology, Faculty of Medicine, Sakarya University; Sakarya-Turkey.
9
Department of Cardiology, Haydarpaşa Numune Training and Research Hospital; İstanbul-Turkey.
10
Department of Cardiology, Recep Tayyip Erdoğan University Training and Research Hospital; Rize-Turkey.
11
Department of Cardiology, Faculty of Medicine, Koç University; İstanbul-Turkey.
12
Department of Cardiology, Faculty of Medicine, Eskişehir Osmangazi University; Eskişehir-Turkey.
13
Department of Cardiology, Faculty of Medicine, Hacettepe University; Ankara-Turkey.

Abstract

OBJECTIVE:

Heart failure (HF) is a progressive clinical syndrome. SELFIE-TR is a registry illustrating the overall HF patient profile of Turkey. Herein, all-cause mortality (ACM) data during follow-up were provided.

METHODS:

This is a prospective outcome analysis of SELFIE-TR. Patients were classified as acute HF (AHF) versus chronic HF (CHF) and HF with reduced ejection fraction (HFrEF), HF with mid-range ejection fraction, and HF with preserved ejection fraction and were followed up for ACM.

RESULTS:

There were 1054 patients with a mean age of 63.3±13.3 years and with a median follow-up period of 16 (7-17) months. Survival data within 1 year were available in 1022 patients. Crude ACM was 19.9% for 1 year in the whole group. ACM within 1 year was 13.7% versus 32.6% in patients with CHF and AHF, respectively (p<0.001). Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta blocker, and mineralocorticoid receptor antagonist were present in 70.6%, 88.2%, and 50.7%, respectively. In the whole cohort, survival curves were graded according to guideline-directed medical therapy (GDMT) scores ≤1 versus 2 versus 3 as 28% versus 20.2% versus 12.2%, respectively (p<0.001). Multivariate analysis of the whole cohort yielded age (p=0.009) and AHF (p=0.028) as independent predictors of mortality in 1 year.

CONCLUSION:

One-year mortality is high in Turkish patients with HF compared with contemporary cohorts with AHF and CHF. Of note, GDMT score is influential on 1-year mortality being the most striking one on chronic HFrEF. On the other hand, in the whole cohort, age and AHF were the only independent predictors of death in 1 year.

Free full text

Supplemental Content

Full text links

Icon for Kare Publishing
Loading ...
Support Center